IMDRF 2023

24th session

25-26 September 2023 | Berlin, Germany

Agenda

Timezone:

Day 2 - 26 September 2023

IMDRF Stakeholder Forum

08:30 - 09:00

Registration and welcome coffee

09:00 - 09:20

Opening remarks

  • Edgar Franke, Parliamentary State Secretary to the Federal Minister of Health, Germany
09:20 - 10:35

Regulatory updates from IMDRF Management Committee and Official Observers including short updates from IMDRF Working Groups

  • Australia - Tracey Duffy, First Assistant Secretary, Medical Devices and Product Quality Division, TGA
  • Brazil - Augusto Bencke Geyer, General Manager, General Management of Health Product Technology, ANVISA
  • Canada - Sally Prawdzik, Acting Director, Policy and International Programs, Health Canada
  • China - Yuan Peng, Division Director, Department of Medical Device Registration, NMPA
  • European Union - Nada Alkhayat, Policy Officer, Directorate General for Health and Food Safety, European Commission & Chloe Spathari, Policy Officer, Directorate General for Health and Food Safety, European Commission
10:35 - 11:00

Coffee break

11:00 - 13:00

Regulatory updates from IMDRF Management Committee and Official Observers including short updates from IMDRF Working Groups

  • Japan - Tomoyuki Miyasaka, Deputy Director, Medical Devices Evaluation Division, MHLW
  • Singapore - Wong Woei Jiuang, Assistant Group Director, Medical Devices Cluster, HSA
  • South Korea - Jeong-Rim Lee, Director General, Medical Device Evaluation Department, MFDS
  • United Kingdom - Laura Squire, Chief Healthcare Quality and Access Office, Medicines and Healthcare products Regulatory Agency (MHRA)
  • United States of America - Kenneth Cavanaugh, Deputy Director, Office of Cardiovascular Devices, US FDA

Official observers:

  • Argentina - Yesica Anastasio, Coordinator of the International Relations Program, National Administration of Drugs, Food and Medical Devices (ANMAT)
  • Switzerland - Markus Wälti, Head of Division, Swiss Agency for Therapeutic Products (Swissmedic)
  • World Health Organization (WHO) - Hiiti Baran SilloUnit Head, Regulation and Safety Department of Regulation and Prequalification
13:00 - 13:50

Lunch break

13:50 - 14:40

Stakeholders sessions

  • African Medical Devices Forum (AMDF) - Paulyne Wairimu, Chair
  • Asia Pacific Economic Cooperation (APEC) - Cheng-Ning (Emily) Wu, Senior Technical Specialist, Division of Medical Devices and Cosmetics, Taiwan Food and Drug Administration
  • Global Harmonization Working Party (GHWP) -  Bryan SoExecutive Secretary General
  • The Global Diagnostic Imaging, Healthcare ICT, and Radiation Therapy Trade Association (DITTA) - Patrick Hope, Chair
  • Global Medical Technology Alliance (GMTA) - Diana Kanecka, Senior Manager International Affairs, MedTech Europe
14:40 - 15:10

Coffee break

15:10 - 16:10

Flash panel - exchange of experience and best practices

Unique Device Identification – 10 years down the road

Moderator: Orla Daly, Policy Officer, Directorate General for Health and Food Safety, European Commission

  • Erin Cutts, Senior International Policy Analyst, U.S. Food and Drug Administration
  • Silvia Ostuni, Legal and Policy Officer, European Commission
  • Tang Jinglong, NMPA
  • Dennis Black, UDI Programme Director, BD
  • Tania Pearson, Regulatory Systems Director, Medtronic
  • Tracey Duffy, First Assistant Secretary of the Medical Devices and Product Quality Division, Therapeutic Goods Administration, Australia

‘Digital Therapeutics’ – Let’s talk qualification and clinical evidence

Moderator: Nada Alkhayat, Policy Officer, Directorate General for Health and Food Safety, European Commission

16:10 - 16:15

Closing remarks

16:30 - 17:30

Information session: EU Medical Devices Regulation – extension of the transition period explained

The aim of this information session is to explain the EU Medical Devices Regulation (MDR) amendment adopted in March 2023 (Regulation (EU) 2023/607) and discuss its practical implementation from different angles.

17:30 - 19:00

Cocktail reception